Holen Sie sich die Stockscreener-App
38.77
1.95%
-0.77
Handel nachbörslich:
38.77
Schlusskurs vom Vortag:
$39.54
Offen:
$39.7
24-Stunden-Volumen:
445.99K
Relative Volume:
0.63
Marktkapitalisierung:
$2.21B
Einnahmen:
$681.88M
Nettoeinkommen (Verlust:
$122.63M
KGV:
18.37
EPS:
2.11
Netto-Cashflow:
$220.18M
1W Leistung:
+2.00%
1M Leistung:
+12.67%
6M Leistung:
+14.50%
1J Leistung:
+22.92%
1-Tages-Spanne:
$38.45
$39.70
1-Wochen-Bereich:
$37.65
$39.92
52-Wochen-Spanne:
$28.14
$41.61
Harmony Biosciences Holdings Inc Stock (HRMY) Company Profile
Firmenname
Harmony Biosciences Holdings Inc
Sektor
Branche
Telefon
(484) 539-9800
Adresse
630 W GERMANTOWN PIKE, PLYMOUTH MEETING
Vergleichen Sie HRMY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HRMY
Harmony Biosciences Holdings Inc
|
38.77 | 2.21B | 681.88M | 122.63M | 220.18M | 2.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
461.68 | 118.90B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
672.98 | 73.95B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
655.13 | 39.81B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
271.31 | 34.99B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
123.77 | 29.67B | 3.30B | -501.07M | 1.03B | -2.1146 |
Harmony Biosciences Holdings Inc Stock (HRMY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-17 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-10-10 | Fortgesetzt | Raymond James | Outperform |
| 2024-09-10 | Eingeleitet | UBS | Buy |
| 2024-06-21 | Eingeleitet | Citigroup | Buy |
| 2024-01-02 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-09-25 | Herabstufung | Goldman | Neutral → Sell |
| 2023-09-07 | Eingeleitet | Berenberg | Buy |
| 2023-04-20 | Eingeleitet | BofA Securities | Neutral |
| 2022-10-14 | Hochstufung | Janney | Neutral → Buy |
| 2022-10-14 | Hochstufung | Jefferies | Hold → Buy |
| 2022-08-03 | Herabstufung | Jefferies | Buy → Hold |
| 2022-07-13 | Herabstufung | Goldman | Buy → Neutral |
| 2022-07-07 | Eingeleitet | Mizuho | Buy |
| 2022-04-14 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-12-01 | Eingeleitet | Oppenheimer | Outperform |
| 2021-11-04 | Eingeleitet | Raymond James | Outperform |
| 2021-09-23 | Eingeleitet | Needham | Buy |
| 2021-03-29 | Hochstufung | Goldman | Neutral → Buy |
| 2020-09-14 | Eingeleitet | Goldman | Neutral |
| 2020-09-14 | Eingeleitet | Jefferies | Buy |
| 2020-09-14 | Eingeleitet | Piper Sandler | Overweight |
Alle ansehen
Harmony Biosciences Holdings Inc Aktie (HRMY) Neueste Nachrichten
HRMY vs. RGEN: Which Stock Is the Better Value Option? - MSN
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) CFO Sandip Kapadia Sells 1,775 Shares - MarketBeat
Insider Selling: Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Insider Sells 1,629 Shares of Stock - MarketBeat
Jeffrey Dierks Sells 13,125 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Stock - MarketBeat
Wall Street Analysts Predict a 28.98% Upside in Harmony Biosciences (HRMY): Here's What You Should Know - Yahoo Finance
Vanguard Group Inc. Expands Stake in Harmony Biosciences Holdings Inc. - GuruFocus.com
SG Americas Securities LLC Buys 6,774 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - MarketBeat
Harmony Biosciences Stock Scores 80-Plus RS Rating - Yahoo! Voices
Harmony Biosciences' chief commercial officer sells $551,575 in stock - MSN
H.C. Wainwright maintains $75 target on Harmony Biosciences stock - MSN
Harmony Biosciences' chief commercial officer sells $551,575 in stock By Investing.com - Investing.com Australia
H.C. Wainwright maintains $75 target on Harmony Biosciences stock By Investing.com - Investing.com Australia
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Position Boosted by Pacer Advisors Inc. - MarketBeat
Harmony Biosciences' (HRMY) Buy Rating Reiterated at HC Wainwright - MarketBeat
H.C. Wainwright Reiterates Buy Rating on Harmony Biosciences Holdings Inc. (HRMY) - StreetInsider.com
Why Harmony Biosciences Shares Are Gaining Attention - TipRanks
Learn to Evaluate (HRMY) using the Charts - Stock Traders Daily
Is Harmony Biosciences Holdings, Inc.'s (NASDAQ:HRMY) Recent Stock Performance Tethered To Its Strong Fundamentals? - Yahoo Finance
Insider Selling: Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) CEO Sells 19,293 Shares of Stock - MarketBeat
Sandip Kapadia Sells 25,000 Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Stock - MarketBeat
Harmony Biosciences (NASDAQ:HRMY) Trading Down 4.5%Here's What Happened - MarketBeat
Harmony Biosciences: Don't Sleep On This Enterprising, Profitable Biotech (NASDAQ:HRMY) - Seeking Alpha
Zacks.com featured highlights include Harmony Biosciences, Ingevity, Gulfport Energy and Pitney Bowes - Yahoo Finance
Harmony Biosciences CFO Sandip Kapadia sells $1m in stock By Investing.com - Investing.com Canada
Harmony Biosciences CFO Sandip Kapadia sells $1m in stock - MSN
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Insider Jeffrey Dierks Sells 1,123 Shares - MarketBeat
Harmony Biosciences Reports Strong Revenue Growth and Outlines Ambitious 2025 Strategy - MSN
HRMY: 3 Under-the-Radar Biotech Stocks Revolutionizing Healthcare - StockNews.com
5-HT2 Agonist Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - GlobeNewswire Inc.
Equities Analysts Offer Predictions for HRMY FY2025 Earnings - MarketBeat
Analysts Set Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) PT at $55.00 - MarketBeat
Harmony Biosciences chief commercial officer sells shares worth $1.15m By Investing.com - Investing.com Canada
ARS Investment Partners LLC Invests $841,000 in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - MarketBeat
Should Value Investors Buy Harmony Biosciences (HRMY) Stock? - Yahoo Finance
Harmony Biosciences stock reaffirms buy rating ahead of Q4 results - MSN
What is HC Wainwright's Forecast for HRMY FY2029 Earnings? - MarketBeat
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Insider Jeffrey Dierks Sells 10,507 Shares - MarketBeat
HC Wainwright Reiterates "Buy" Rating for Harmony Biosciences (NASDAQ:HRMY) - MarketBeat
Harmony Biosciences stock reaffirms buy rating ahead of Q4 results By Investing.com - Investing.com Australia
Hennion & Walsh Asset Management Inc. Raises Stock Holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) - MarketBeat
Harmony Biosciences officer sells shares worth $388,840 By Investing.com - Investing.com Canada
Harmony Biosciences officer sells shares worth $388,840 - Investing.com
A Glimpse Into The Expert Outlook On Harmony Biosciences Through 7 Analysts - Benzinga
Harmony Biosciences chief commercial officer sells shares worth $265,946 By Investing.com - Investing.com South Africa
(HRMY) Trading Advice - Stock Traders Daily
Harmony Biosciences chief commercial officer sells shares worth $265,946 - Investing.com
How Much Upside is Left in Harmony Biosciences (HRMY)? Wall Street Analysts Think 39.48% - MSN
Why Harmony Biosciences (HRMY) Might be Well Poised for a Surge - MSN
Finanzdaten der Harmony Biosciences Holdings Inc-Aktie (HRMY)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.95%
2.39%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):